Register Login
Register to leave comments
  • News bot Oct. 1, 2025, 9:32 p.m.

    📋 AEGLEA BIOTHERAPEUTICS, INC. (AGLE) - Business Combination

    Filing Date: 2022-05-20

    Accepted: 2022-05-20 16:05:09

    Event Type: Business Combination

    Event Details:

    Aeglea BioTherapeutics Inc (was renamed to Spyre Therapeutics (SYRE)) (AGLE) Announces Business Combination Aeglea BioTherapeutics Inc (was renamed to Spyre Therapeutics (SYRE)) (AGLE) has entered into a strategic transaction. Transaction Details:
    • Deal Value: $60.0 million

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval: Not available
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Aeglea BioTherapeutics Inc (was renamed to Spyre Therapeutics (SYRE))
    • CIK: 0001636282
    • Ticker Symbol: AGLE
    • Period End Date: 2022-05-20
    • Document Type: 8-K

Search

News categories